Menu
In progress
In progress
Next step
In 2021, antalgic drugs represented a market of 71,3 billion dollars.
An average increase of 3,92% is expected between 2022 and 2030.
Pain management is the health challenge of the 21st century !
Spin off from CNRS and AMU is a biopharmaceutical research company developing a new scientific approach for next-generation treatments, based on a true breakthrough innovation derived from the mechanism of action of an endogenous and secreted protein modulating the pain signal.